204 related articles for article (PubMed ID: 26562613)
1. Application of Ga(68) -DOTA-exendin-4 PET/CT to localize an occult insulinoma.
Cuthbertson DJ; Banks M; Khoo B; Antwi K; Christ E; Campbell F; Raraty M; Wild D
Clin Endocrinol (Oxf); 2016 May; 84(5):789-91. PubMed ID: 26562613
[No Abstract] [Full Text] [Related]
2. Localization of Hidden Insulinomas with ⁶⁸Ga-DOTA-Exendin-4 PET/CT: A Pilot Study.
Antwi K; Fani M; Nicolas G; Rottenburger C; Heye T; Reubi JC; Gloor B; Christ E; Wild D
J Nucl Med; 2015 Jul; 56(7):1075-8. PubMed ID: 25999434
[TBL] [Abstract][Full Text] [Related]
3. Glucagon-Like Peptide-1 Receptor PET/CT with 68Ga-NOTA-Exendin-4 for Detecting Localized Insulinoma: A Prospective Cohort Study.
Luo Y; Pan Q; Yao S; Yu M; Wu W; Xue H; Kiesewetter DO; Zhu Z; Li F; Zhao Y; Chen X
J Nucl Med; 2016 May; 57(5):715-20. PubMed ID: 26795291
[TBL] [Abstract][Full Text] [Related]
4. Insulinoma induced hypoglycemia in a type 2 diabetic patient.
Ravnik-Oblak M; Janez A; Kocijanicic A
Wien Klin Wochenschr; 2001 Apr; 113(9):339-41. PubMed ID: 11388080
[TBL] [Abstract][Full Text] [Related]
5. 68Ga DOTA-Exendin PET/CT for Detection of Insulinoma in a Patient With Persistent Hyperinsulinemic Hypoglycemia.
Parihar AS; Vadi SK; Kumar R; Mittal BR; Singh H; Bal A; Walia R; Shukla J; Sinha SK
Clin Nucl Med; 2018 Aug; 43(8):e285-e286. PubMed ID: 29877881
[TBL] [Abstract][Full Text] [Related]
6. Pre-clinical evaluation of [(68)Ga]Ga-DO3A-VS-Cys(40)-Exendin-4 for imaging of insulinoma.
Selvaraju RK; Velikyan I; Asplund V; Johansson L; Wu Z; Todorov I; Shively J; Kandeel F; Eriksson B; Korsgren O; Eriksson O
Nucl Med Biol; 2014 Jul; 41(6):471-6. PubMed ID: 24857864
[TBL] [Abstract][Full Text] [Related]
7. [Insulinoma and octreotide].
Lamberts SW; de Herder WW; Kwekkeboom DJ; Bruining HA; Krenning EP
Ned Tijdschr Geneeskd; 1992 May; 136(19):907-10. PubMed ID: 1594063
[No Abstract] [Full Text] [Related]
8. [Recurrent hypoglycemia due to an occult insulinoma].
Breuer TG; Breuer HL; Menge BA; Giese A; Uhl W; Schmidt WE; Tannapfel A; Wild D; Nauck MA; Meier JJ
Internist (Berl); 2016 Apr; 57(4):385-9. PubMed ID: 26873007
[TBL] [Abstract][Full Text] [Related]
9. [Various aspects of diagnosis and therapy of organic hyperinsulinism].
Trofimov VM; Kalinin AP; Nechaĭ AI
Klin Med (Mosk); 1991 Mar; 69(3):102-6. PubMed ID: 2067323
[No Abstract] [Full Text] [Related]
10. Volume Replacement Fluid Demarks Benign Insulinoma With 68Ga-DOTA-Exendin-4 PET/CT.
Antwi K; Nicolas G; Fani M; Christ E; Wild D
Clin Nucl Med; 2019 May; 44(5):e347-e348. PubMed ID: 30889001
[TBL] [Abstract][Full Text] [Related]
11. 68Ga-NOTA-exendin-4 PET/CT in detection of occult insulinoma and evaluation of physiological uptake.
Luo Y; Yu M; Pan Q; Wu W; Zhang T; Kiesewetter DO; Zhu Z; Li F; Chen X; Zhao Y
Eur J Nucl Med Mol Imaging; 2015 Mar; 42(3):531-2. PubMed ID: 25398421
[No Abstract] [Full Text] [Related]
12. 68Ga-Exendin-4 PET/CT in Evaluation of Endoscopic Ultrasound-Guided Ethanol Ablation of an Insulinoma.
Luo Y; Li J; Yang A; Yang H; Li F
Clin Nucl Med; 2017 Apr; 42(4):310-311. PubMed ID: 28134698
[TBL] [Abstract][Full Text] [Related]
13. Type 2 diabetes and insulinoma: An unusual association.
Maiza JC; Wantz C
Diabetes Metab; 2015 Nov; 41(5):432-3. PubMed ID: 26386553
[No Abstract] [Full Text] [Related]
14. Morphologically 'invisible' proinsulin - secreting adenoma detected by Ga-68 Exendin-4 (GLP-1 Receptor) positron emission tomography/CT.
Werner C; Lupp A; Drescher R; Freesmeyer M; Mireskandari M; Stoykow C; Bauschke A; Müller UA
J Med Imaging Radiat Oncol; 2018 Jun; 62(3):370-374. PubMed ID: 29399966
[TBL] [Abstract][Full Text] [Related]
15. [(68)Ga-exendin-4 PET-CT for the localization of occult insulinomas: a prospective cohort study].
Luo YP; Pan QQ; Li F; Yu M; Xing XP; Zhang TP; Zhao YP
Zhonghua Wai Ke Za Zhi; 2018 Nov; 56(11):837-842. PubMed ID: 30392304
[No Abstract] [Full Text] [Related]
16. Ectopic insulinoma diagnosed by 68Ga-Exendin-4 PET/CT: A case report and review of literature.
Zhang X; Jia H; Li F; Fang C; Zhen J; He Q; Liu M
Medicine (Baltimore); 2021 Apr; 100(13):e25076. PubMed ID: 33787590
[TBL] [Abstract][Full Text] [Related]
17.
Tuzcu SA; Pekkolay Z; Kılınç F; Tuzcu AK
J Nucl Med Technol; 2017 Sep; 45(3):198-200. PubMed ID: 28798227
[TBL] [Abstract][Full Text] [Related]
18. Selective Arterial Calcium Stimulation with Hepatic Venous Sampling in Patients with Recurrent Endogenous Hyperinsulinemic Hypoglycemia and Metastatic Insulinoma: Evaluation in Five Patients.
Thompson SM; Vella A; Service FJ; Thompson G; Andrews JC
J Vasc Interv Radiol; 2017 Dec; 28(12):1745-1749. PubMed ID: 29157479
[TBL] [Abstract][Full Text] [Related]
19. Insulinoma causing hypoglycemia in a patient with type 2 diabetes.
Lei WY; Wang TE; Chen TL; Chang WH; Yang TL; Wang CY
J Formos Med Assoc; 2007 May; 106(5):392-6. PubMed ID: 17561474
[TBL] [Abstract][Full Text] [Related]
20. [Intermittent disturbances of perception during fasting in a 46-year-old female patient].
Ravens S; Scheit L
Internist (Berl); 2020 Sep; 61(9):964-968. PubMed ID: 32734334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
